{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:19:06Z","timestamp":1783559946382,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41386-020-0740-x","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T11:45:45Z","timestamp":1593603945000},"page":"1870-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4457-1908","authenticated-orcid":false,"given":"Pak Wing Calvin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys G.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit Wa Sherry","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Ming Edwin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Ming Christy","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2766-8476","authenticated-orcid":false,"given":"Yi Nam","family":"Suen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yim Lung Eric","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Ming Paul","family":"Au Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Fung Henry","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pak Chung","family":"Sham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3562-0683","authenticated-orcid":false,"given":"Mattia","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Lai","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Hai Eric","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"key":"740_CR1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archpsyc.1980.01780190097012","volume":"37","author":"KS Kendler","year":"1980","unstructured":"Kendler KS. The nosologic validity of paranoia (simple delusional disorder): a review. Arch Gen Psychiatry. 1980;37:699\u2013706.","journal-title":"Arch Gen Psychiatry"},{"key":"740_CR2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association.","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","edition":"5th ed."},{"key":"740_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","volume":"64","author":"J Per\u00e4l\u00e4","year":"2007","unstructured":"Per\u00e4l\u00e4 J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isomets\u00e4 E, Pirkola S, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64:19\u201328.","journal-title":"Arch Gen Psychiatry"},{"key":"740_CR4","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/schbul\/sbx056","volume":"43","author":"WC Chang","year":"2017","unstructured":"Chang WC, Wong CSM, Chen EYH, Lam LCW, Chan WC, Ng RMK, et al. Lifetime prevalence and correlates of schizophrenia-spectrum, affective, and other non-affective psychotic disorders in the Chinese adult population. Schizophr Bull. 2017;43:1280\u201390.","journal-title":"Schizophr Bull"},{"key":"740_CR5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eurpsy.2018.09.010","volume":"55","author":"CM D\u00edaz-Caneja","year":"2019","unstructured":"D\u00edaz-Caneja CM, Cervilla JA, Haro JM, Arango C, de Portugal E. Cognition and functionality in delusional disorder. Eur Psychiatry. 2019;55:52\u201360.","journal-title":"Eur Psychiatry."},{"key":"740_CR6","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archpsyc.1982.04290080012003","volume":"39","author":"KS Kendler","year":"1982","unstructured":"Kendler KS. Demography of paranoid psychosis (delusional disorder). Arch Gen Psychiatry. 1982;39:890.","journal-title":"Arch Gen Psychiatry."},{"key":"740_CR7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/schbul\/sbq125","volume":"38","author":"A Marneros","year":"2010","unstructured":"Marneros A, Pillmann F, Wustmann T. Delusional disorders-are they simply paranoid schizophrenia? Schizophr Bull. 2010;38:561\u20138.","journal-title":"Schizophr Bull."},{"key":"740_CR8","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1017\/S0033291716001501","volume":"46","author":"V Peralta","year":"2016","unstructured":"Peralta V, Cuesta MJ. Delusional disorder and schizophrenia: a comparative study across multiple domains. Psychol Med. 2016;46:2829\u201339.","journal-title":"Psychol Med."},{"key":"740_CR9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archpsyc.1980.01780300059007","volume":"38","author":"KS Kendler","year":"1981","unstructured":"Kendler KS, Hays P. Paranoid psychosis (delusional disorder) and schizophrenia: a family history study. Arch Gen Psychiatry. 1981;38:547\u201351.","journal-title":"Arch Gen Psychiatry"},{"key":"740_CR10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1192\/bjp.bp.106.029660","volume":"191","author":"P Lepping","year":"2007","unstructured":"Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis. Br J Psychiatry. 2007;191:198\u2013205.","journal-title":"Br J Psychiatry"},{"key":"740_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/YIC.0000000000000020","volume":"29","author":"A Gonz\u00e1lez-Rodr\u00edguez","year":"2014","unstructured":"Gonz\u00e1lez-Rodr\u00edguez A, Molina-Andreu O, Penad\u00e9s R, Bernardo M, Catal\u00e1n R. Effectiveness of long-acting injectable antipsychotics in delusional disorders with nonprominent hallucinations and without hallucinations. Int Clin Psychopharmacol. 2014;29:177\u201380.","journal-title":"Int Clin Psychopharmacol"},{"key":"740_CR12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JCP.0b013e3182905796","volume":"33","author":"MR Mews","year":"2013","unstructured":"Mews MR, Quante A. Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder. J Clin Psychopharmacol. 2013;33:512\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"740_CR13","first-page":"125","volume":"44","author":"V Ruiz","year":"2016","unstructured":"Ruiz V, Torra M, Bernardo M. Antipsychotic response in delusional disorder and schizophrenia: a prospective cohort study. Actas Esp Psiquiatr. 2016;44:125\u201335.","journal-title":"Actas Esp Psiquiatr"},{"key":"740_CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol. 2015;29:97\u2013115.","journal-title":"J Psychopharmacol."},{"key":"740_CR15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012;69:776\u201386.","journal-title":"Arch Gen Psychiatry"},{"key":"740_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00113-3","volume":"35","author":"J Hietala","year":"1999","unstructured":"Hietala J, Syv\u00e4lahti E, Vilkman H, Vuorio K, R\u00e4kk\u00f6l\u00e4inen V, Bergman J, et al. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res. 1999;35:41\u201350.","journal-title":"Schizophr Res."},{"key":"740_CR17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-018-0042-4","volume":"24","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Turkheimer FE, et al. Determinants of treatment response in first-episode psychosis: an 18 F-DOPA PET study. Mol Psychiatry. 2019;24:1502\u201312.","journal-title":"Mol Psychiatry."},{"key":"740_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2009.108","volume":"16","author":"P Fusar-Poli","year":"2009","unstructured":"Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry. 2009;16:67\u201375.","journal-title":"Mol Psychiatry."},{"key":"740_CR19","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","volume":"91","author":"J Reith","year":"1994","unstructured":"Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci USA. 1994;91:11651\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"740_CR20","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","volume":"97","author":"A Abi-Dargham","year":"2000","unstructured":"Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA. 2000;97:8104\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"740_CR21","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, Van Dyck CH, Gil R, D\u2019Souza CD, Erdos J, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA. 1996;93:9235\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"740_CR22","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamapsychiatry.2017.2943","volume":"74","author":"S Jauhar","year":"2017","unstructured":"Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, et al. A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry. 2017;74:1206.","journal-title":"JAMA Psychiatry"},{"key":"740_CR23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","volume":"22","author":"AH Ashok","year":"2017","unstructured":"Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, et al. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol Psychiatry. 2017;22:666.","journal-title":"Mol Psychiatry."},{"key":"740_CR24","first-page":"261","volume":"8","author":"CL Hui","year":"2013","unstructured":"Hui CL, Chang WC, Chan SK, Lee EH, Tam WW, Lai DC, et al. Early intervention and evaluation for adult-onset psychosis: the JCEP study rationale and design. Early Interv Psychiatry. 2013;8:261\u20138.","journal-title":"Early Interv Psychiatry"},{"key":"740_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0920-9964(92)90004-O","volume":"6","author":"H H\u00e4fner","year":"1992","unstructured":"H\u00e4fner H, Riecher-R\u00f6ssler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res. 1992;6:209\u201323.","journal-title":"Schizophr Res."},{"key":"740_CR26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archpsyc.1982.04290080001001","volume":"39","author":"JF Leckman","year":"1982","unstructured":"Leckman JF. Best estimate of lifetime psychiatric diagnosis. Arch Gen Psychiatry. 1982;39:879.","journal-title":"Arch Gen Psychiatry."},{"key":"740_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376.","journal-title":"Schizophr Bull."},{"key":"740_CR28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","volume":"39","author":"NC Andreasen","year":"1982","unstructured":"Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39:784\u20138.","journal-title":"Arch Gen Psychiatry"},{"key":"740_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","volume":"163","author":"D Addington","year":"1993","unstructured":"Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the calgary depression scale. Br J Psychiatry. 1993;163:39\u201344.","journal-title":"Br J Psychiatry"},{"key":"740_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.schres.2005.09.008","volume":"81","author":"N Saraswat","year":"2006","unstructured":"Saraswat N, Rao K, Subbakrishna D, Gangadhar B. The Social Occupational Functioning Scale (SOFS): a brief measure of functional status in persons with schizophrenia. Schizophr Res. 2006;81:301\u20139.","journal-title":"Schizophr Res."},{"key":"740_CR31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","volume":"74","author":"A Egerton","year":"2013","unstructured":"Egerton A, Chaddock CA, Winton-Brown TT, Bloomfield MA, Bhattacharyya S, Allen P, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry. 2013;74:106\u201312.","journal-title":"Biol Psychiatry."},{"key":"740_CR32","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2967\/jnumed.114.143958","volume":"55","author":"S Roy","year":"2014","unstructured":"Roy S, Wang WT, Carass A, Prince JL, Butman JA, Pham DL. PET attenuation correction using synthetic CT from ultrashort echo-time MR imaging. J Nucl Med. 2014;55:2071\u20137.","journal-title":"J Nucl Med"},{"key":"740_CR33","first-page":"1905","volume":"53","author":"S Chen","year":"2012","unstructured":"Chen S, Leung YL, Cheng T, Wong KN, Ho CL. Functional analysis of 18F-DOPA PET for the diagnosis of Parkinson\u2019s disease. J Nucl Med. 2012;53:1905","journal-title":"J Nucl Med"},{"key":"740_CR34","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2967\/jnumed.116.178160","volume":"57","author":"S Chen","year":"2016","unstructured":"Chen S, Leung YL, Au Yeung KM, Cheung W, Wong KN, Cheng K, et al. Comparative study of 18F-DOPA PET\/MR and PET\/CT in quantification accuracy and clinical applicability for Parkinson\u2019s disease: a static and dynamic data analysis. J Nucl Med. 2016;57:1830","journal-title":"J Nucl Med"},{"key":"740_CR35","first-page":"553","volume":"59","author":"CL Ho","year":"2018","unstructured":"Ho CL, Chan YK, Chen S, Leung YL, Mak KF, Chen YH. Patlak analysis of striatal dopamine synthesis capacity in earlier and later-onset psychotic illnesses with 18F-DOPA brain PET\/MR imaging. J Nucl Med. 2018;59:553.","journal-title":"J Nucl Med"},{"key":"740_CR36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl B. FreeSurfer. Neuroimage. 2012;62:774\u201381.","journal-title":"Neuroimage."},{"key":"740_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"740_CR38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/mp.2011.20","volume":"16","author":"O Howes","year":"2011","unstructured":"Howes O, Bose S, Turkheimer F, Valli I, Egerton A, Stahl D, et al. Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry. 2011;16:885.","journal-title":"Mol Psychiatry."},{"key":"740_CR39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archgenpsychiatry.2010.10","volume":"67","author":"LS Kegeles","year":"2010","unstructured":"Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 2010;67:231\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"740_CR40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1192\/bjp.bp.114.159087","volume":"208","author":"V Vicens","year":"2016","unstructured":"Vicens V, Radua J, Salvador R, Anguera-Camos M, Canales-Rodr\u00edguez EJ, Sarro S, et al. Structural and functional brain changes in delusional disorder. Br J Psychiatry. 2016;208:153\u20139.","journal-title":"Br J Psychiatry"},{"key":"740_CR41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1192\/bjp.165.4.474","volume":"165","author":"RJ Howard","year":"1994","unstructured":"Howard RJ, Almeida O, Levy R, Graves P, Graves M. Quantitative magnetic resonance imaging volumetry distinguishes delusional disorder from late-onset schizophrenia. Br J Psychiatry. 1994;165:474\u201380.","journal-title":"Br J Psychiatry"},{"key":"740_CR42","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0893-133X(01)00421-3","volume":"26","author":"K Morimoto","year":"2002","unstructured":"Morimoto K. Delusional disorder: molecular genetic evidence for dopamine psychosis. Neuropsychopharmacology.2002;26:794\u2013801.","journal-title":"Neuropsychopharmacology."},{"key":"740_CR43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway. Schizophr Bull. 2009;35:549\u201362.","journal-title":"Schizophr Bull."},{"key":"740_CR44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/jcbfm.1993.85","volume":"13","author":"P Cumming","year":"1994","unstructured":"Cumming P, Leger GC, Kuwabara H, Gjedde A. Pharmacokinetics of plasma 6-[18F] fluoro-L-3, 4-dihydroxyphenylalanine ([18F] FDOPA) in humans. J Cereb Blood Flow Metab. 1994;13:668\u201375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"740_CR45","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/brain\/awz093","volume":"142","author":"M Avram","year":"2019","unstructured":"Avram M, Brandl F, Cabello J, Leucht C, Scherr M, Mustafa M, et al. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms. Brain. 2019;142:1813\u201326.","journal-title":"Brain."},{"key":"740_CR46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C","volume":"29","author":"P Cumming","year":"1998","unstructured":"Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse.1998;29:37\u201361.","journal-title":"Synapse."},{"key":"740_CR47","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1073\/pnas.1417219112","volume":"112","author":"L Deserno","year":"2015","unstructured":"Deserno L, Huys QJ, Boehme R, Buchert R, Heinze HJ, Grace AA, et al. Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making. Proc Natl Acad Sci USA. 2015;112:1595\u2013600.","journal-title":"Proc Natl Acad Sci USA"},{"key":"740_CR48","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1177\/0271678X16684137","volume":"37","author":"I Lopes Alves","year":"2017","unstructured":"Lopes Alves I, Meles SK, Willemsen AT, Dierckx RA, Marques da Silva AM, Leenders KL, et al. Dual time point method for the quantification of irreversible tracer kinetics: a reference tissue approach applied to [18F]-FDOPA brain PET. J Cereb Blood Flow Metab. 2017;37:3124\u201334.","journal-title":"J Cereb Blood Flow Metab"},{"key":"740_CR49","first-page":"635","volume":"15","author":"Y Kumakura","year":"2009","unstructured":"Kumakura Y, Cumming P. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches. J Neurosci. 2009;15:635\u201350.","journal-title":"J Neurosci."},{"key":"740_CR50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopsych.2018.07.003","volume":"85","author":"S Jauhar","year":"2019","unstructured":"Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Natesan S, et al. The Effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first-episode psychosis: a positron emission tomography study. Biol Psychiatry. 2019;85:79\u201387.","journal-title":"Biol Psychiatry."},{"key":"740_CR51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300103","volume":"28","author":"G Gr\u00fcnder","year":"2002","unstructured":"Gr\u00fcnder G, Vernaleken I, M\u00fcller MJ, Davids E, Heydari N, Buchholz HG, et al. Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology. 2002;28:787\u201394.","journal-title":"Neuropsychopharmacology."},{"key":"740_CR52","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry. 2012;169:1203\u201310.","journal-title":"Am J Psychiatry"},{"key":"740_CR53","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awt264","volume":"136","author":"OD Howes","year":"2013","unstructured":"Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 2013;136:3242\u201351.","journal-title":"Brain."},{"key":"740_CR54","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/npp.2014.87","volume":"39","author":"MA Bloomfield","year":"2014","unstructured":"Bloomfield MA, Pepper F, Egerton A, Demjaha A, Tomasi G, Mouchlianitis E, et al. Dopamine function in cigarette smokers: an [18 F]-DOPA PET study. Neuropsychopharmacology. 2014;39:2397\u2013404.","journal-title":"Neuropsychopharmacology."},{"key":"740_CR55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopsych.2015.11.009","volume":"80","author":"L Rademacher","year":"2016","unstructured":"Rademacher L, Prinz S, Winz O, Henkel K, Dietrich CA, Schmaljohann J, et al. Effects of smoking cessation on presynaptic dopamine function of addicted male smokers. Biol Psychiatry. 2016;80:198\u2013206.","journal-title":"Biol Psychiatry."},{"key":"740_CR56","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/npp.2016.258","volume":"42","author":"E Kim","year":"2017","unstructured":"Kim E, Howes OD, Veronese M, Beck K, Seo S, Park JW, et al. Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [18F] DOPA PET study. Neuropsychopharmacology. 2017;42:941\u201350.","journal-title":"Neuropsychopharmacology."},{"key":"740_CR57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000327899","volume":"45","author":"I Ibanez-Casas","year":"2012","unstructured":"Ibanez-Casas I, Cervilla JA. Neuropsychological research in delusional disorder: a comprehensive review. Psychopathology. 2012;45:78\u201395.","journal-title":"Psychopathology."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0740-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0740-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:11:45Z","timestamp":1723162305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-0740-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":57,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-0740-x","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]},"assertion":[{"value":"23 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}